Teva Pharmaceutical to Pay $225 Million in Fines for Price Fixing
Teva Pharmaceutical, the world's largest generic drugmaker, has agreed to pay a fine of $225 million as part of a settlement with the U.S. Department of Justice (DOJ) over price-fixing charges. The settlement also includes the divestiture of its copycat version of a cholesterol drug as well as other terms aimed at resolving the allegations.